Theresa Lavalle

Title: The Innovative Contributions of Theresa Lavalle

Introduction: Theresa Lavalle is a prominent inventor based in Rockville, MD (US). She has made significant strides in the field of medical research, particularly in the classification of tumors through innovative methods. Her work focuses on the detection and quantification of insulin receptor isoforms, which has important implications for cancer diagnosis and treatment.

Latest Patents: Theresa Lavalle holds 1 patent for her invention titled "Quantification of IR-A and IR-B for tumor classification." This patent relates to compositions and methods for detecting and quantifying the expression of insulin receptor isoform A (IR-A) and/or insulin receptor isoform B (IR-B) in tissue samples. The methods outlined in her patent are crucial for diagnosing and classifying tumors based on the expression of these insulin receptor isoforms.

Career Highlights: Throughout her career, Theresa has demonstrated a commitment to advancing medical science. Her work at Medimmune Limited has positioned her as a key player in the development of innovative diagnostic methods. Her research has the potential to improve patient outcomes through more accurate tumor classification.

Collaborations: Theresa has collaborated with notable colleagues, including Jiaqi Huang and Chris Morehouse. These partnerships have enhanced her research efforts and contributed to the success of her projects.

Conclusion: Theresa Lavalle's contributions to the field of medical research exemplify the impact of innovation on healthcare. Her patent for tumor classification methods showcases her dedication to improving diagnostic techniques and patient care.